Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-22
2011-03-22
Eyler, Yvonne L (Department: 1619)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C977S902000, C977S904000, C977S905000, C977S906000, C977S915000, C540S557000
Reexamination Certificate
active
07910577
ABSTRACT:
Described are injectable formulations of nanoparticulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise nanoparticulate olanzapine.
REFERENCES:
patent: 4783484 (1988-11-01), Violante et al.
patent: 4826689 (1989-05-01), Violanto et al.
patent: 4997454 (1991-03-01), Violante et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5298262 (1994-03-01), Na et al.
patent: 5302401 (1994-04-01), Liversidge et al.
patent: 5336507 (1994-08-01), Na et al.
patent: 5340564 (1994-08-01), Illig et al.
patent: 5346702 (1994-09-01), Na et al.
patent: 5352459 (1994-10-01), Hollister et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5429824 (1995-07-01), June
patent: 5470583 (1995-11-01), Na et al.
patent: 5494683 (1996-02-01), Liversidge et al.
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5518187 (1996-05-01), Bruno et al.
patent: 5518738 (1996-05-01), Eickhoff et al.
patent: 5534270 (1996-07-01), De Castro
patent: 5543133 (1996-08-01), Swanson et al.
patent: 5552160 (1996-09-01), Liversidge et al.
patent: 5560931 (1996-10-01), Eickhoff et al.
patent: 5560932 (1996-10-01), Bagchi et al.
patent: 5565188 (1996-10-01), Wong et al.
patent: 5569448 (1996-10-01), Wong et al.
patent: 5571536 (1996-11-01), Eickhoff et al.
patent: 5573783 (1996-11-01), Desieno et al.
patent: 5580579 (1996-12-01), Ruddy et al.
patent: 5585108 (1996-12-01), Ruddy et al.
patent: 5587143 (1996-12-01), Wong
patent: 5591456 (1997-01-01), Franson et al.
patent: 5622938 (1997-04-01), Wong
patent: 5637584 (1997-06-01), Larsen
patent: 5662883 (1997-09-01), Bagchi et al.
patent: 5665331 (1997-09-01), Bagchi et al.
patent: 5703232 (1997-12-01), Bunnell et al.
patent: 5718388 (1998-02-01), Czekai et al.
patent: 5718919 (1998-02-01), Ruddy et al.
patent: 5736541 (1998-04-01), Bunnell et al.
patent: 5741522 (1998-04-01), Violante et al.
patent: 5747001 (1998-05-01), Wiedmann et al.
patent: 5776496 (1998-07-01), Violante et al.
patent: 5834025 (1998-11-01), De Garavilla et al.
patent: 5862999 (1999-01-01), Czekai et al.
patent: 6020487 (2000-02-01), Bunnell et al.
patent: 6045829 (2000-04-01), Liversidge et al.
patent: 6068858 (2000-05-01), Liversidge et al.
patent: 6153225 (2000-11-01), Lee et al.
patent: 6165506 (2000-12-01), Jain et al.
patent: 6221400 (2001-04-01), Liversidge et al.
patent: 6251895 (2001-06-01), Larsen et al.
patent: 6264922 (2001-07-01), Wood et al.
patent: 6267989 (2001-07-01), Liversidge et al.
patent: 6270806 (2001-08-01), Liversidge et al.
patent: 6316029 (2001-11-01), Jain et al.
patent: 6375986 (2002-04-01), Ryde et al.
patent: 6428814 (2002-08-01), Bosch
patent: 6431478 (2002-08-01), Reed et al.
patent: 6432381 (2002-08-01), Liversidge et al.
patent: 6582285 (2003-06-01), Czekai et al.
patent: 6592903 (2003-07-01), Ryde et al.
patent: 6617321 (2003-09-01), Allen et al.
patent: 6656504 (2003-12-01), Bosch et al.
patent: 6742734 (2004-06-01), Reed et al.
patent: 6745962 (2004-06-01), Reed et al.
patent: 6811767 (2004-11-01), Bosch et al.
patent: 6906062 (2005-06-01), Chhabada et al.
patent: 6908626 (2005-06-01), Cooper et al.
patent: 2002/0012675 (2002-01-01), Jain et al.
patent: 2002/0119916 (2002-08-01), Hassan
patent: 2002/0165225 (2002-11-01), Hamied et al.
patent: 2004/0067936 (2004-04-01), Reguri et al.
patent: 2004/0198721 (2004-10-01), Dolitzky et al.
patent: 2007/0004706 (2007-01-01), Petho et al.
patent: 2007/0043021 (2007-02-01), Solomon
patent: 0 499 299 (2000-08-01), None
patent: WO 00/53164 (2000-09-01), None
patent: WO 02/098565 (2002-12-01), None
patent: WO 2004/032980 (2004-04-01), None
patent: WO 2004/032980 (2004-04-01), None
Tohen, Mauricio et al.; Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression,2003, American Medical Association, Arch Gen Psychiatry, vol. 60, Nov. 2003, pp. 1079-1088.
Love, Raymond C.; Strategies for increasing treatment compliance: The role of long-acting antipsychotics; 2002; American Society of Health-System Pharmacistis; Am J Health-Syst Pharm, vol. 59, Nov. 15, 2002, Supplement 8, pp. S10-S15.
The Merck Index, 10thEd., p. 1106 (Merck & Co., Rahway, NJ, 1983).
Jenkins Scott
Liversidge Elaine Merisko
Liversidge Gary
Elan Pharma International Limited
Eyler Yvonne L
Fox Rothschild LLP
Green Ivan
LandOfFree
Injectable nanoparticulate olanzapine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable nanoparticulate olanzapine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable nanoparticulate olanzapine formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2744381